In B-CLL patients, the expression of TRPC1 was higher in pERK1/2+ patients, compared to pERK1/2−, with respect to the control samples (B and T cells from a healthy donor), with levels similar to the Jok-E1A cell line. The gene discussed is TRPC1; the disease is B-cell chronic lymphocytic leukemia.